11:08 AM EST, 01/08/2025 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Wednesday it appointed James Young as chief financial officer, succeeding Sean Murphy, who will continue as chief manufacturing, strategy and business development officer.

Young previously served as the company's senior vice president of investor relations and treasurer, the company said.

TriSalus said it promoted Richard Marshak to chief commercial officer and Jodi Devlin to chief of clinical strategy and operations.

The changes became effective Monday.

TriSalus shares were down 1.2% in recent trading.

Price: 5.09, Change: -0.06, Percent Change: -1.17